Clinical Trial Update: To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAR502 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study to investigate safety, tolerability, pharmacokinetics and pharmacodynamics of BAR502 in healthy subjects; nonalcoholic steatohepatitis (NASH) is l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• BAR502

Snippet

Sponsor: BAR Pharmaceuticals s.r.l. | Conditions: NASH | Phase 1 | Status: RECRUITING